Paxlovid
Showing 26 - 49 of 49
CKD Patients Treated With Nirmatrelvir-ritonavir
Recruiting
- COVID-19
- +2 more
-
Shatin, New Territories, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Nov 21, 2022
COVID-19 Trial (PF-07321332 (nirmatrelvir)/ritonavir)
Not yet recruiting
- COVID-19
- PF-07321332 (nirmatrelvir)/ritonavir
- (no location specified)
Aug 2, 2022
Post-COVID-19 Syndrome, Long COVID, Long Covid19 Trial in Stockholm (Nirmatrelvir/ritonavir, Placebo/ritonavir)
Not yet recruiting
- Post-COVID-19 Syndrome
- +9 more
- Nirmatrelvir/ritonavir
- Placebo/ritonavir
-
Stockholm, SwedenKarolinska Institutet
Apr 20, 2023
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19), Immunocompromised Trial
Not yet recruiting
- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
- +4 more
- Nirmatrelvir
- +2 more
-
Cooperstown, New York
- +10 more
Dec 11, 2022
Biological Availability Trial (Nirmatrelvir/ ritonavir, Nirmatrelvir/Ritonavir, Nirmatrelvir/ritonavir)
Not yet recruiting
- Biological Availability
- Nirmatrelvir/ ritonavir
- +2 more
- (no location specified)
Sep 14, 2022
COVID-19 Pneumonia Trial (Low-Dose Radiation Therapy)
Not yet recruiting
- COVID-19 Pneumonia
- Low-Dose Radiation Therapy
- (no location specified)
Jan 22, 2023
COVID-19 Trial (Chinese Herb, Placebo)
Not yet recruiting
- COVID-19
- Chinese Herb
- Placebo
- (no location specified)
Mar 25, 2023
TURN-COVID Biobank: The Dutch Cohort Study for Evaluation of Use
Recruiting
- COVID-19
- casirivimab with imdevimab
- +2 more
-
Amsterdam, Noord Holland, Netherlands
- +3 more
Jan 13, 2022
Pharmacokinetics, Healthy Volunteers Trial in Brussels (Rosuvastatin, Nirmatrelvir/ritonavir)
Not yet recruiting
- Pharmacokinetics
- Healthy Volunteers
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Jun 1, 2023
Timings for Awake Prone Positioning in Covid-19 Patients
Not yet recruiting
- Coronavirus Pneumonia
- (no location specified)
Apr 3, 2023
Safety of Voriconazole in Critically Ill Elderly Patients
Recruiting
- Invasive Fungal Infection
- other antifungal agents,breathing machine
-
Zhengzhou, Henan, ChinaZhengzhou Central Hospital affiliated to Zhengzhou University
Nov 16, 2023
COVID-19 Complications in High-risk Subjects Infected by
Recruiting
- SARS-CoV Infection
- Covid19
- biobank
-
Agen, France
- +36 more
Apr 6, 2022
SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
-
Derby, United KingdomUniversity of Derby
Jun 21, 2023
COVID-19 Trial (Meplazumab foe injection, Normal saline)
Not yet recruiting
- COVID-19
- Meplazumab foe injection
- Normal saline
- (no location specified)
Jan 16, 2023
COVID-19 Trial in Singapore (TCM intervention, Placebo intervention)
Recruiting
- COVID-19
- TCM intervention
- Placebo intervention
-
Singapore, Singapore
- +1 more
Oct 24, 2022
Coronavirus Trial in Oxford (SARS-CoV-2 virus)
Recruiting
- Coronavirus
- SARS-CoV-2 virus
-
Oxford, Oxon, United Kingdom
- +2 more
Jan 5, 2023
Immunodeficiency, Immunosuppression, HIV Trial in La Jolla (Access to Cue Health COVID-19 Remote testing and treatment for
Recruiting
- Immunodeficiency
- +8 more
- Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
-
La Jolla, CaliforniaScripps Research
Dec 22, 2022
COVID-19 Trial (Manzi Guben granules)
Not yet recruiting
- COVID-19
- Manzi Guben granules
- (no location specified)
Feb 8, 2023
COVID-19 Trial in France, Germany, United Kingdom (COVID-19 convalescent and vaccinated plasma, Current standard of care)
Recruiting
- COVID-19
- COVID-19 convalescent and vaccinated plasma
- Current standard of care
-
Besançon, France
- +10 more
May 3, 2022
COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,
Recruiting
- COVID-19 Pandemic
- COVID-19 Vaccines
- Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
- CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
-
Surabaya, East Java, IndonesiaDr. Soetomo General Hospital
Jun 21, 2023